Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Danish Crown subsidiary takes majority stake in Shanghai Natural Casing Food acquisition news : DAT-Schaub, a subsidiary of global meat processing company Danish Crown is all set to… bySrinathMarch 31, 2018
